Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene

Surgery

Volumn 126, Issue 6, 1999, Pages 1188-1194

  Kraimps, Jean Louis ^a,b,c   Canzian, Federico ^a,b,c   Jost, Claudine ^a,b,c   Menet, Emmanuel ^a,b,c   Amati, Patricia ^a,b,c   Levillian, Pierre ^a,b,c   Harach, Ruben ^a,b,c   Lesueur, Fabienne ^a,b,c   Barbier, Jacques ^a,b,c   Romeo, Giovanni ^a,b,c   Bonneau, Dominique ^a,b,c  

^a University of Poitiers   (France)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHROMOSOME 19P; CLINICAL ARTICLE; GENE MAPPING; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; THYROID TUMOR;

EID: 0032754478     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2099.102606     Document Type: Article

References (25)

1. 1. Greig WR, Boyle JA, Duncan A, Nicol J, Gray MJ, Buchanan WW, et al. Genetic and non-genetic factors in simple goitre formation: evidence from a twin study. QJ Med 1967;36:175-88.
2. 2. Burgess JR, Duffield A, Wilkinson SJ, Ware R, Greenaway TM, Percival J, et al. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 1997;82:345-8.
3. 3. Cooper DS, Axelrod L, DeGroot LJ, Vickery AL Jr, Maloof F. Congenital goiter and the development of metastatic follicular carcinoma with evidence for a leak of nonhormonal iodide: clinical, pathological, kinetic and biochemical studies and a review of the literature. J Clin Endocrinol Metab 1981;52:294-306.
4. 4. Couch RM, Hughes IA, DeSa DJ, Schiffrin A, Guyda H, Winter JS. An autosomal dominant form of adolescent multinodular goiter. Am J Hum Genet 1986;39:811-6.
5. 5. Gorson D. Familial papillary carcinoma of the thyroid. Thyroid 1992;2:131-2.
6. 6. Kraimps JL, Bouin-Pineau MH, Amati P, Mothes D, Bonneau D, Marechaud R, et al. Familial papillary carcinoma of the thyroid. Surgery 1997;121:715-8.
7. 7. Ozaki O, Ito K, Kobayashi K, Suzuki A, Manabe Y, Hosoda Y. Familial occurrence of differentiated, nonmedullary thyroid carcinoma. World J Surg 1988;12:565-71.
8. 8. Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment. Arch Surg 1995;130:892-7.
9. 9. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86:1600-8.
10. 10. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, et al. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 1997;61:1123-30.
11. 11. Collin GB, Munch A, Mu JL, Naggert JK, Olsen AS, Nishina PM. Physical and genetic mapping of novel microsatellite polymorphisms on human chromosome 19. Genomics 1996;37:125-30.
12. 12. Ott J. Computer-simulation methods in human linkage analysis. Proc Natl Acad Sci USA 1989;86:4175-8.
13. 13. Lathrop GM, Lalouel GM. Easy calculation of Iod scores and genetic risk on small computers. Am J Hum Genet 1984;36:460-5.
14. 14. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996;58:1347-63.
15. 15. Ashworth LK, Batzer MA, Brandriff B, Branscomb E, de Jong P, Garcia E, et al. An integrated metric physical map of human chromosome 19. Nat Genet 1995;11:422-7.
16. 16. Katoh R, Harach HR, Williams ED. Solitary, multiple, and familial oxyphil tumors of the thyroid gland. J Pathol 1998; 186:292-9.
17. 17. Harach HR, Williams GT, Williams ED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 1994;25:549-61.
18. 18. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997; 16:64-7.
19. 19. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993;365:649-51.
20. 20. Duprez L, Parma J, Van Sande J. Allgeier A, Leclere J, Schvartz C, et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 1994;7:396-401.
21. 21. Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R, et al. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 1989; 4:1457-62.
22. 22. Di Renzo MF, Olivero M, Ferro S, Prat M, Bongarzone I, Pilotti S, et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 1992;7:2549-53.
23. 23. Pasini B, Ceccherini I, Romeo G. RET mutations in human-disease. Trends Genet 1996;12:138-44.
24. 24. Lesueur F, Stark M, Tocco T, Ayadi H, Delisle MJ, Goldgar D, et al. Genetic heterogeneity in familial nonmedullary thyroid carcinoma. Exclusion of linkage to RET, MNG1 and TCO in 56 families. J Clin Endocrinol Metab 1999 84:2157-62.
25. 25. Nakashima M, Eguchi K, Ishikawa N, Yamashita I, Sakai M, Ida H, et al. Expression of adhesion molecule ICAM-I (CD54) in thyroid papillary adenocarcinoma. J Endocrinol Invest 1994; 17:843-8.